separated from the ultrafiltrate into still impure fractions which appeared to contain one or more glucopeptides with glutamic acid, glycine and cysteine present amongst other amino acids (Patel et al., 1984b) .
Human urogenital secretions and about 20% of tested sera also had resistance-inducing activity (Martin et al., 1981 (Martin et al., , 1982 . In addition, the resistance-inducing activities of sera correlated with some patterns of female gonorrhoea (Martin et al., 1984) . Thus, host-induced resistance to complement-mediated killing may be important in gonorrhoea. On ultrafiltration of human serum, some resistance-inducing activity was found in low-M, fractions but, in contrast to guinea-pig serum, far more activity remained in high-M, fractions. The low-M, RIF from humans was similar to the guinea-pig material in ultrafiltration characteristics and acid and heat lability (Martin et al., 1981) . Furthermore, two glucopeptide fractions containing glutamic acid, glycine and cysteine and other amino acids obtained from extracts of human red blood cells (RBC) had a small resistance-inducing activity (Weiss et al., 1971; Patel et al., 1984b) . Lysates of guinea-pig and human RBC were 30-to 60-fold more active in inducing resistance than the corresponding sera (Patel et al., 1984~) . As for the sera, however, almost all the guinea-pig RIF was low-M,, whereas the human factors were predominantly, but not exclusively, high-M, (Patel et al., 1984a) . Some low-M, RIF is present in human RBC lysates and this paper describes its fractionation and identification. Initially, extraction from RBC and fractionation were based on the methods of Weiss et al. (1971, and private communication) and Patel et al. (1984b) . This preliminary work provided information about the properties of low-M, RIF and of potential impurities which was used in designing the method described.
METHODS
Bacterial strain and growth conditions. Neisseria gonowkae [strain BSlyagar)], media, culturing and counting procedures were as described previously (Penn et al., 1976; Veale et al., 1981 ; Patel et al., 19846) .
Generation of serum-resisrant gonococci, test for resistance to killing byfiesh human serum and an approximate assay o f H F actiuity. These were as described by Patel et al. (19846) . One RIF unit is the amount of inducing factor which, under standard conditions previously described (Patel et a/., 1984b), will convert 50% of gonococci [2 x 104 strain Wagar)] to resistance t o killing by fresh human serum.
Release of lOw-M, resistance-inducing activityfrom blood cells. Packed RBC and buffy coat cells, obtained from 1 litre of human peripheral blood by centrifugation for 1Smin at 4°C and 2000 g, were resuspended in approximately 400 ml10 m-Tris/HCl buffer, pH 6.5. The mixture was gently shaken for 1 h at 37 "C, transferred in 25-30 ml portions to 1-9 cm diameter dialysis bags and dialysed for 24 h at 25 "C against the smallest possible volume (typically 800 ml) 10 m-Tris/HCl buffer, pH 6.5. The long period of dialysis at elevated temperature was appropriate because control experiments had established that the release of low-M, RIF, possibly from a high-Mr precursor, was both time-and temperaturedependent.
Chromatography on QAE-Sephadex A25 and gelfiltration. A 2.6 x 70 cm column of QAE-Sephadex A25 was equilibrated at 4 "C with 10 m-Tris/HCl, pH 6.5, at a flow rate of 60 ml h-l. The diffusate from the lysed blood cells was then loaded onto the column at 25 "C by continuous recycling during the 24 h dialysis process with a flow rate of 60 ml h-I. Most of the low-M, RIF adsorbed to the column, but a significant amount (about 30% of total recovery) remained in the diffusate. This material was pre-loaded onto the QAE-Sephadex A25 column at 4 "C before the next batch of diffusate was processed. After the adsorption stage, the column was transferred to a cold room at 4 "C and bound material was eluted at 60 ml h-I with a 1-44 litre linear gradient of 0-0.3 M-NaCI in 10 m~-Tris/HCl, pH 6.5. After the gradient, any material remaining on the column was eluted with 0.3 M-NaC1 in 10 m~-Tris/HCl, pH 6-5. The eluate was monitored at 279 nm and 5 ml fractions were tested without concentration for Punjication of RIF by high-pressure liquid chromatography (HPLC). The freezedried material from the Sephadex G10 column was dissolved in 8 0 0~1 water and applied in sixteen 50 p1 aliquots to a DEAE 5PW HPLC column (7-5 mm internal diameter x 7-5 cm) which was protected by a 6 mm internal diameter x 1 cm guard column (Toyo Soda Manufacturing Co.). Two LDC model I11 dual-head pumps were driven by an LDC gradient master (Laboratory Data Control). The column was equilibrated with 10 mwNaC1 in 1 m-Tris/HCI, pH 7.0, and the aliquot was eluted at a flow rate of 1 ml min-' with a 30 ml linear gradient prepared from 15 ml of the same buffer and 15 ml of 90 mwNaC1 in 1 m-Tris/HCl, pH 5.0. The ehiate was monitond at 210 nm and 500 pl fractions were collected. The column was then washed at 1 ml m i r l for 4 min with 90 mac-NaCl in 1 m-Tris/HCl, pH 5.0, and re-equilibrated with 10 m-NaC1 in 1 m~-Tris/HCl, pH 7.0, for 15 min before the next aliquot was applied.
The leastcontamhated fractions with appreciable RIF from 12 of the 16 aliquots were combined, desalted by passage through 8 1.5 x 160 cm column of Sephadex G10 in 1 ~Y -N~H~P O J N~~H . € W~ buffer, pH 6-8, freeze dried and redissdved in 400-500 pl distillad water. This sampk was then apphed in two portions to the same DEAE 5PW HPLC column which had been equilibrated with 30 rmr-NaCl in 1 m-Tris/HCl, pH 6.5, and eluted isocratically at 1 ml min-' with the same buffer. Fractions which contained leastwntaminated RIF activity were combined from both portions, desalted by filtration through Sephadex G10 and equilibrated with 1 m-NaH,PO4/NatHFO4 buffer, pH 6-8. The samples containing active material were bulked, free= dried, and repeatedly redissolved in deuterium oxide and freeze dried in preparation for NMR spectrwcopy. Conrpariwns of the acid and treat labilitfes of low-M, RIF fiom Mood d cytidiw 5'-mtmophospbNacetylneurcmmic acid (CMP-NANA). The acid labilities of 10w-M~ RIF from Mood and CMP-NANA were compared by adding 5 pl samples containing approximately equal numbers of RIF units or a mixture of 2.5 pl of each material to 245 p1 10 m-citric acid/sodium citrate buffm which had been adjusted to pH 4.0,4.5,5-0 and 6.5. After 1 h at 37 "C, the pH of each sample was adjusted to 6.5 with 0.5 M-NaOH. Each sample was then diluted with an equal volume of defined medium (DM; Vedc et uf., 1981) and assayed for RIF activity.
Heat labilities were compared by adding lop1 of sample (lOw-M, RIF or CMP-NANA, each containing approximately equal numbers of RIF units) or 5 p.l RIF plus 5 pl CMP-NANA to 490 p.l 10 m-citrate buffer pH 6.5 and incubating at 75 "C. Aliquots (100 pl) were removed after 0,15,45 and 60 min, immediately cooled on ice, diluted with an equal volume of DM and assayed for RIF activity. were added to 100 pl of 1 ~M-CMP, 0.1 m-CMP, 0.01 mM-CMP ar distilled water and tested for RIF activity. A control with 1 &MP but no low-M, RIF or CMP-NANA was also included.
NMRspectroscqpy. We are indebted to Qrs J. Feeney and T. Frenkeil at the Biomedical NMR centre, National Institute for Medical Research, Mill Hill, London, UK, for examining the 500 MHz lH NMR spectra of the preparation from blood: measurements were made on the Bruker AM 500 spectrometer. The freezedried preparation was dissolved in deuterium oxide (0.5 ml) and contained approximately 40 m-sodium phosphate.
Chemzcal analysis. Total peptide was measured by the Lowry method using bovine Serum albumin as standard and total carbohydrate by the anthrone method with glucose as standard. Amino acids, except cysteine, were analysed by the methods described by Patel et al. (19846) after 6 M-HC~ hydrolysis under vacuum for 24 h at 100 "C. After this treatment, little cysteine was detected (as cystine). Hence, if any cystefne had been detected by this method, it was assayed accurately as cysteic acid after hydrdysis and oxidation of a separate sample by performic acid. &Bar analysis was as dcscribad by Patel et ul. (1984b) . Glutathione, measured by the method of Bernt 8t Bergmeyer (1974) . could be detected at 0.5 pg ml-l. 
RESULTS

Initial extraction of low-M, RIF from blood cells and preliminary characterization
Preliminary experiments were done in the belief that low-M, RIF might be a giumpeptide containing glutamic acid, glycine, cysteine and possibly other aminu acids (see Introduction).
Hence, the low-M, RIF was extracted from human RBC with saline EDTA essentially as nominal cut-off 30000 Da). LOW-Mr RIF passed through a YM5 membrane (nominal cut-off 5OOO Da) but was retained on a YCOS membrane (nominal cut-off 500 Da). About 70% of the total RIF activity was recovered from ultrafiltration, of which about 70% was high-M, and 30% low-M,. Further purification of the YCOS retentate was achieved by gel filtration through Biogel P2 and anion-exchange chromatography on QAE-Sephadex A25. This procedure indicated that the active component had an M, of about SOO-lOOO and contained acid groups. The RIF activity was associated with substantial quantities of glucose, glycine, glutamic acid and cysteine, and with smaller quantities of aspartic acid and serine. This analysis was similar to that of the fractions obtained from guinea-pig serum and RBC lysates (Patel et al., 19843, and unpublished observations) , and from human RBC by Weiss et al. (197 1, and private communication) . At this pint, appreciable quantities of glutathione were detected in the fractions, explaining the relatively high content of glutamic acid, glycine and cysteine. However, neither reduced nor oxidized glutathione was active in the RIF assay, even at concentrations as high as 1 mg ml-l. Glutathione was removed from the low-M, RIF as described below. RIF activity was heat-and acid-labile (after 1 h at 75 "C, pH 6.5, and 37 "C, pH 4, respectively). At room temperature and at 37 "C it was stable at pH 6.5, the pH of the medium used for induction of serum resistance (Veale et al., 1981 ; Patel et al., 19846) . It was unaffected by incubation for 18 h at 37 "C and pH 5 with agarose-bound neuraminidase (Sigma).
Sampks of RIF of comparable activity and acid lability, and again associated with sugar, glutathione and other amino acids, were also obtained by fractionating water lysates (16 h, 4 "C) of RBC that had previously been extracted with saline EDTA. This indicated that the extraction of low-M, RIF by saline EDTA was incompkte. The purification protocol subsequently used was therefore designed to release as much low-M, RIF as possible, rapidly, and in a form suitable for immediate anion-exchange chromatography. In the later stages of the preliminary fractionation, some low-M, RIF activity passed through YC05 membranes. Hence, Sephadex G 10 was used both to desalt and to fractionate RIF after each ion-exchange procedure. A kmg column of QAE-Sephadex A25 and a moderately slow flow rate were selected to optimize the separation of RIF from contaminating glutathione and carbohydrate-containing components by exploiting differences in both size and charge.
Release and purifcatwn of low-M, RIF
During initial dialysis of the bld-cell lysate for 24 h at 25 "C the difisate was continuously loaded onto the QAE-Sephadex A25 column. About 60% of the total RIF activity of the lysate was retained as high-M, RIF in the dialysate (Table 1) . About 30% of the total recovered diffused low-M, RIF remained unadsorbed on the QAE-Sephadex A25 column at the end of the dialysis period (Table 1) and was processed with the next batch of diffusate (see Methods).
The elution profile of the diffusate on the first QAE-Sephadex A25 column using a linear gradient of NaCl in 10 m-Tris/HCl, pH 6.5, is shown in Fig. 1 (a) . RIF activity was eluted by about 0.26 M-NaC1. Considerable amounts of peptide (27 mg) and carbohydrate (270 mg) were removed in early fractions (1-75) before the gradient was applied. The combined active fractions contained about 70% of the total recovered low-M, RIF with some peptide (5.6 mg) and carbohydrate (2-9 mg) ( Table 1) .
The active material from the first QAE-Sephadex A25 column was separated from several impurities that absorbed at 279 nm during filtration through Sephadex G10 (Fig. lb) . The recovery of activity in the combined active fractions was 70% ( Table 1) . Salt was removed and the eluate contained less peptide and far less carbohydrate than the QAE-Sephadex A25 eluate (Table I) .
Residual glutathione and further carbohydrate were then removed by a second QAE-Sephadex A25 column ( Fig. 1 c) . The recovery of activity in the bulked active fractions was 61 % (Table 1) . h a l t i n g with Sephadex G10 was accomplished with 82% recovery of activity and no change in peptide and carbohydrate contamination ( Table 1) aliquot is shown in Fig. 2(a) . The RIF activity coincided with a shoulder preceding a major contaminant which was eluted in the gradient by about 50m-NaC1. Less separation of components occurred with four of the aliquots: for the remaining 12, fractions with the highest ratio of RIF activity to contaminant (fractions 8 and 9 in Fig. 2a) were pooled, desalted by filtration through a column of Sephadex G10, freeze dried and redissolved in 0.5 ml water. The material was applied to the second HPLC column in two portions, and eluted isocratically (Fig.  2 b) . Fractions 6-8 of both portions were combined, and desalted by filtration through Sephadex G10 which had been equilibrated with a phosphate buffer, pH 6.8. The samples containing the active material were bulked (20 ml), freeze dried and prepared for NMR spectroscopy. Only a single absorption peak at 210 nm was detected when a sample of the final RIF preparation was applied to and eluted isocratically from the HPLC column in 30m-NaC1, 1 m-Tris/HCl, pH6.5 (Fig. 2 4 . Major losses of activity occurred in the two HPLC fractionations because of the need to select only the leading RIF-active fractions ( Fig. 2a, b) , leaving much activity in later neighbouring fractions. In the first separation from 1 litre of blood, the preliminary stages of which are summarized in Table 1 , the final preparation had 1400 RIF units in 0.5 ml deuterium oxide. In a second separation from 2.5 litres of blood, the final preparation had 7500 RIF units in 0.5 ml deuterium oxide.
Examination of the preparation from blood by NMR and UV spectroscopy
N M R spectroscopy, done mainly on the sample containing 7500 RIF units, indicated that at least four components were present. The major component appeared to be a sugar (possibly related to fructose). Two further components were pyrimidine nucleotides and were subsequently shown to have 'H spectra characteristic of uridine diphospho-N-acetylglucosamine and uridine diphospho-N-acetylgalactosamine. An additional compound contained aliphatic groups. There was no evidence for guanine, adenine, thymine, glycine, cysteine, glutamic acid, threonine, aspartic acid or other amino acids in the major components detected.
The strength of the major signals indicated a concentration of approximately 1 m~ for the main components, equivalent to about 300 pg of each (assuming an M, indicated by gel filtration and ultrafiltration of approximately 600) in the 0.5 ml deuterium oxide. Thus, with several components present, a very rough estimate of the total material was of the order of 1 mg.
The abrbancy maximum of 26Onm in the U V spectrum of the final preparation was in accord with the presence of pyrimidine nucleotides. 
The high resistance-inducing activity of CMP-NANA : comparison of its proprties with those of the preparation from blood
The NMR results and the extreme acid lability of RIF guided the subsequent experiments. Uridine diphospho-N-acetylglucosamine and uridine diphospho-N-acetylgalactosamine, the presence of which had been demonstrated by NMR, were much less acid-labile than RIF and were inactive when tested at 100 p~ in the RIF assay. However, CMP-NANA is an extremely acid-labile pyrimidine nucleotide and a synthetic (enzymically prepared) commercial sample proved active in the RIF assay at 0.2 p~. In contrast, CMP, UDP, cytidine diphosphoribitol and N-acetylneuraminic acid (NANA) were inactive at 100 p~. Two different commercial samples of CMP-NANA contained 525 and 550 RIF units per nmol(0-6 pg), i.e. approximately 1 RIF unit per ng.
After being examined by NMR, during which the sample was frozen and thawed several times, the preparation from blood was compared with CMP-NANA in various tests. When applied to the same HPLC column that had been used for the fractionation and eluted with 30 mM-NaC1, 1 m-Tris/HCl, pH 6.5, its profile at 210 nm (Fig. 3a) showed a main peak (retention time 12*7min, coinciding with RIF activity) and a small one (retention time 14-3 min). Clearly, some degradation had taken place since the original separation (Fig. 24 . Under the same conditions, the profile of CMP-NANA (20 1 1 of 0.1 m~) showed a single peak (retention time 1243 min) (Fig. 3b) . When CMP-NANA and the preparation from blood were mixed together, the profile (Fig. 3c) showed a single peak (retention time 12.7 min) with a slight shoulder on the trailing end. A 10 m-citrate buffer was used (see Methods).
The preparation from blood, CMP-NANA, and a mixture of the two were indistinguishable in the extents to which their RIF activities were reduced at pH 5-0,4*5 and 4.0 compared with controls at pH 6.5 after 1 h at 37 "C ( Table 2) . Similarly, the extents to which their activities were reduced after 15,45 and 60 min at 75 "C and pH 6.5 were almost identical (Table 2) . Even more significant, the resistance-inducing activities of both CMP-NANA and the preparation from blood were inhibited in an h o s t identical fashion by increasing concentrations of CMP (Table  3) . Such inhibition is characteristic of sialylation reactions in which CMP-NANA is the donor substrate (Bernacki, 1975) . Table 3 . Inhibition of the RIF activity of the preparation from human blood and of CMP-NANA by CMP Solutions (100 pl) of the blood preparation or CMP-NANA (0-4 pf) w e e mixed with 100 pl water, or 0.01, 0.1 or 1 m-CMP. The RIF activity of 500 pbf CMP done was <1 R W unit ml-l. If RIF is CMP-NANA, then the relative resistance-inducing activities indicated that only about 1% of the final preparation from blood (tMimated around 1 mg from NMR, see above) would have been CMP-NANA. Re-examination of the original lH spectrum indicated some very small m a t i c signals which could be assigned to a small amount of cytidine nucleotide, but at the prevailing signal-tp.noise ratio, unequivocal evidence for CMP-NANA could not be obtained from this sample.
RIF activity (unit
DISCUSSION
Identification of the low-M, RIF in lysates of human blood cells has been diflicult because of the minute quantities that are present. Initially, extraction and fractionation were based on previous work (Weiss et al., 1971 and private communication; Patel et ul., 19846) in the belief that low-M, RIF might be a glucopeptide containing sfutamic acid, glycine, cysteine and possibly other amino acids. These studies showed that human lOW-Mr RIF had an M, between 500 and 1O00, contained acid groups and was very acid-and heat-labile. They also showed that the relatively high contents of glutasnic acid, glycine and cysteine of the fractionated material were due to contaminating, biologically inactive, glutathione which ujeluted with lw-M, RIF from anionexchange columns. Carbohydrate contamination was also present. Corresponding material from guinea-pig serum or R3C lysates was not examined for glutathione and carbohydrate contamination because effort was coneeatrated on the human material. It was probable, however, that they were present in the fractions previously described (Patel et al., 1984b) and that the biological activity was due to the W e cause as that of the human material (see below).
The process for extracting RIF activity from blood was redesigned after first demonstrating that low-M, RIF was released in blood cell lysates in a time and temperaturedependent manner. A prolonged dialysis of lysates at 25 "C was used to obtain adequate amouats of activity in the 10w-M~ form (Table 1) . Fractionation on two QAE-Sephadex A25 C O~I M S with intermediate desalting by Sephadex G10 columns produced considerable purification of low-M, RIF with reasonable recovery of activity at each stage (Fig. 1, Table 1 ). Glutathione was eluted from the second column just before the lOW-Mr RIF but separate from it (Fig. lc) . HPLC revealed a complex mixture ( Fig. 2a) from which, after two separations, a fraction showing only one peak was eventually obtained (Fig. 2c) by selecting leading RIF active fractions ( Fig. 2a, 6) .
There was insufficient material for conventional analysis. NMR spectroscopy showed that despite extensive purification and the elution of RIF activity as a single symmetrical peak during HPLC, the final preparation was still a mixture. NMR evidence indicating the presence of pyrimidine nucleotides was supported by the UV absorption maximum of 260nm. The extreme acid lability of low-M, RIF guided the choice of CMP-NANA m a poawiMe candidate. Fortunately, commercial synthetic (enzymically prepared) material was available and it proved very active in inducing gonococcal resistance to killing by human serum. In contrast, several other relatively acid-stable pyrimidine nwleotides, notably uridine diphospho-N-acetylglum-amine and uridine diphospho-N-acetylgalactosamine, whose presence had been indicated by NMR and whose adsorption maxima are about 260 nm, were inactive, as was NANA itself.
The low-M, RIF from blood and CMP-NANA were identical in six properties. They coeluted from HPLC (Fig. 3 ) and they were indistinguishable in their patterns of acid and heat inactivation ( Table 2) . More importantly, the resistance-inducing activity of both was inhibited by CMP (Table 3) , which is known to inhibit the sialylation reaction of CMP-NANA (Bernacki, 1975) . Also, treatment of crude low-M, RIF with neuraminidase did not destroy its activity:
CMP-NANA, unlike most other NANA-containing compounds, is resistant to this enzyme (Gottschalk, 1972) . Finally, when CMP-NANA or low-M, RIF from blood were used to induce resistance in gonococci, the accompanying profound changes in their lipopolysaccharide (LPS) patterns were indistinguishable (Parsons et ul., 1988) . While identity in any one of these properties could be fortuitous, identity in all six is overwhelming evidence that CMP-NANA or some closely related analogue is probably the lOW-Mr RIF in blood cell lysates. If it is, biological activities indicate that only about 40 pg CMP-NANA was present in the cell lysate from 1 litre of blood and the fractionated preparation was only about 1 %pure. With this minute amount in a mixture, the presence of CMP-NANA in the preparation from blood could not be established unequivocally by NMR, although some consistent signals were obtained. We cannot, therefore, exclude the possibility that low-M, RIF may not be CMP-NANA or a closely related analogue but another compound with identical biological properties. CMP-NANA is present in mammalian tissue and bacteria including meningococci; its main function appears to be as the donor of NANA to glycoproteins, carbohydrates and gangliosides under the influence of sialyltransferases (Gottschalk, 1972; Brackmann et al., 1983) . It is synthesized from CTP and NANA and split into CMP and NANA by synthetases and hydrolaws, respectively, both enzymes being widespread (Gottschalk, 1972; Brackmann et ul., 1983) . It has been found in many types of mammalian cells (Gottschalk, 1972; Cary & Hirschberlg, 1979; Igatashi et d., 1985; Ferwerda et uf., 1983) , including human cervical epithelial cells (Scudder & Chantler, 1981) . As far as the authors are aware, it has not been demonstrated before in RBC nor in bum coat phagocytes, which contain high RIF activity (Pate1 et al., 1988) . Is CMP-NANA available to gonococci in uiw? It is primarily intracellular and could be used by gonococci which sometimes grow within cells (Parsons et al., 1985) . Only minute quantities would be present in blood and body fluids because it does not readily pass across cell membranes (Brackmann et al., 1983) . However, only small amounts would be needed to stimulate gonomcal resistance to serum killing. It must be remembered that the majority of RIF activity in bloodcell lysates is in high#, form. On the reasonable assumption that high-and low-M, RIF are connected, it appears that CMP-NANA or a related precursor may be held on some large carrier molecule. This molecule may be intracellular, but it could be in the membrane of the cell or on the surface, or even be in the process of being transported across the membrane. Thus, it may allow access of CMP-NANA or a related precursor to any gonococci near or attached to the cells. The nature of the carrier molecule and the availability of CMP-NANA to gonococci in this form must be investigated. Sidylation is probably the basis of resistance induction since the latter was abolished for both CMP-NANA and the preparation from blood by CMP, a known inhibitor of sialylation by CMP -NANA (Bemacki, 1975) . The most likely acceptor of the sialic acid groups is LPS, and there is clear evidence that LPS is changed when gonococci are induced to serum resistance. In previous work with impure low-M, RIF from guinea-pig blood, pyocin sensitivities and silverstained LPS patterns of proteinase K digests on SDS-PAGE gels were different for susceptible and resistant organisms (Winstanley et d., 1984; Tan et d., 1986 ). Also, as mentioned above, striking differences in LPS patterns of such digests occurred when gonococci were induced to resistance by either low-M, RIF from human blood or CMP-NANA.
It is probable that these changes are responsible for the acquisition of serum resistance. LPS is normally the target antigen in gonococci for the bactericidal antibody (mostly IgM) of fresh human serum (Glynn & Ward, 1970; Schmlnik et d., 1979; Rice et al., 1980; Apicella et ul., 1986) . Resistance or susceptibility to fresh human serum is determined to a considerable degree by LPS structure, which can vary with both strain and growth conditions (Guymon et al., 1978 (Guymon et al., , 1982 Apicella et al., 1987; Grifis et al., 1987; Stephens & Shafer, 1987) . Sialylation of LPS by CMP-NANA would lead to a change of structure which may affect target sites for bactericidal IgM.
If conversion of gonococci to resistance by CMP-NANA occurs in the host, the LPS of in u i m grown gonococci might be expected to contain NANA residues. Such gonococci have not been examined, and investigations of in oitr~grown gonococci do not provide a clear answer. Wiseman & Caird (1977) concluded that NANA was present in the LPS of 38 strains on the basis of gas-liquid chromatography and d o u r reactions. Other studies mention glucose, galactose, N-acetylglucosamine, N-acetylgalactosamine, and a heptcme, but not NANA (Perry et  al., 1975; Gri& et al., 1987) . NANA is present in the capsular polysaccharides of group B streptococci, K1-type Escherichia coli and Neisseria meningitidis (Robbins et al., 1980) . Studies with CMP-NANA radiolabelled in the NANA moiety should show whether or not sialylation of the LPS occurs during resistance induction.
It is generally agreed that the host can influence the production of virulence determinants (Brown & Williams, 1985; Smith, 1988) . However, particular aspects of the environment rit uitx, which lead to the production of specific virulence determinants have not been identified except for the recognition that iron deprivation of some Gram-negative pathogens induces new outermembrane proteins (Brown & Williams, 1985) . Ow work provides a much-needed specific example of this important general principle of pathogenicity.
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